| J B Chemicals & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506943 |
NSE Symbol : JBCHEPHARM |
P/E(TTM) : 40.56 |
|
ISIN Demat : INE572A01036 |
Div & Yield% : 0.84 |
EPS(TTM) : 44.97 |
|
Book Value(₹) : 237.66 |
Market Cap(₹Cr) : 28,571.90 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,722.92 | 3,298.64 | 2,884.16 | 2,189.88 | 1,892.00 |
| Other Income | 34.74 | 34.67 | 8.65 | 38.61 | 115.92 |
| Stock Adjustments | -15.53 | 49.22 | 27.48 | 25.57 | 15.70 |
| Total Income | 3,742.13 | 3,382.53 | 2,920.29 | 2,254.06 | 2,023.62 |
| EXPENDITURE : | |||||
| Raw Materials | 1,236.70 | 1,158.29 | 1,064.21 | 769.27 | 641.46 |
| Power and Fuel Cost | 83.83 | 87.95 | 91.44 | 71.37 | 62.60 |
| Other Manufacturing Expenses | 143.79 | 120.93 | 106.13 | 97.36 | 84.69 |
| Selling and Administration Expenses | 491.43 | 446.93 | 394.90 | 305.91 | 204.68 |
| Miscellaneous Expenses | 86.92 | 88.96 | 90.33 | 63.58 | 55.96 |
| Employee Benefit Expenses | 646.79 | 565.38 | 499.95 | 399.06 | 305.98 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,052.68 | 914.09 | 673.34 | 547.52 | 668.25 |
| Interest | 9.12 | 40.52 | 34.31 | 4.95 | 7.19 |
| Gross Profit | 1,043.56 | 873.57 | 639.03 | 542.57 | 661.06 |
| Depreciation | 166.45 | 135.24 | 111.99 | 71.28 | 67.36 |
| Profit Before Tax | 877.11 | 738.33 | 527.04 | 471.29 | 593.70 |
| Current Tax | 191.69 | 145.49 | 83.35 | 122.50 | 137.50 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 32.88 | 49.49 | 54.80 | -12.21 | 9.12 |
| Reported Net Profit | 652.54 | 543.36 | 388.89 | 361.00 | 447.08 |
| Extraordinary Items | 20.00 | 11.70 | 2.92 | 27.75 | 46.97 |
| Adjusted Net Profit | 632.54 | 531.66 | 385.97 | 333.25 | 400.11 |
| Adjustment below Net Profit | -4.43 | -3.71 | 0.13 | 0.07 | -12.50 |
| Profit/Loss Balance carried down | 2,452.82 | 2,070.16 | 1,808.73 | 1,575.18 | 1,214.01 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 237.04 | 156.99 | 127.59 | 127.52 | 73.42 |
| P & L Balance carried down | 2,863.89 | 2,452.82 | 2,070.16 | 1,808.73 | 1,575.18 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,550.00 | 1,225.00 | 887.50 | 825.00 | 825.00 |
| Dividend Per Share(Rs) | 15.50 | 12.25 | 17.75 | 16.50 | 16.50 |
| Earnings Per Share-Unit Curr | 41.92 | 35.01 | 50.26 | 46.71 | 57.85 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 216.94 | 185.98 | 315.65 | 272.21 | 233.75 |
| Book Value(Adj)-Unit Curr | 216.94 | 185.98 | 157.83 | 136.11 | 116.88 |